EUDA Health Holdings Limited, referred to as “EUDA” or “the Company,” is a Singapore-based non-invasive healthcare provider operating across Asia, with a primary focus on Singapore, Malaysia, and China. The company announced today that it will introduce EUDA Helixé 2.0 in January 2026, representing a next-generation upgrade of its premium youthful vitality and longevity supplement. EUDA Helixé 2.0 delivers advancements in formulation strength, ingredient technology, delivery systems, packaging design, and global market readiness.
EUDA Helixé 2.0 includes a 20% increase in New Zealand–sourced deer placenta powder, with the dosage raised from 100 mg to 120 mg, strengthening the supplement’s position as a high-potency vitality formulation. As part of the formulation upgrade, L-glutathione has been substituted with D-alpha-tocopherol (Vitamin E, 1.4 mg equivalent). This adjustment is intended to enhance antioxidant stability, support cellular defense, improve skin health, and boost overall youthful vitality, aligning EUDA Helixé 2.0 with long-term wellness and anti-aging goals.
Progressive Encapsulation and Preservation Technology
EUDA Helixé 2.0 uses an upgraded element preservation and offer platform planned to improve stability, absorption efficacy, and shelf life:
Freeze Drying: Powder-based elements are freeze-dried to preserve nutrient effectiveness while eliminating moisture without changing molecular properties.
Refining Technology: Oil-based elements experience refining to enhance stability, decrease allergenic and reactive capacity, and increase resistance to heat and light.
Nitrogen Encapsulation: Nitrogen defense diminishes oxidation and hydrolysis, encompassing product shelf life.
Nano emulsification (Replaced Enteric Coating): Nano-sized preparation enhances bioavailability, solubility, and absorption speed, permitting effective nutrient delivery as compared to an old-style enteric coating.
This nano-based delivery process allows EUDA Helixé 2.0 to achieve a smaller capsule size and is planned to enhance the user experience with effective nutrient absorption while preserving or improving functional efficiency.
Positioning EUDA Helixé for Worldwide Development
The upcoming January 2026 introduction of EUDA Helixé 2.0 demonstrates EUDA Health’s commitment to continuous innovation, scientific advancement, and scalable global wellness solutions. With improved formulation strength, progressive delivery technology, refined packing, and extended market convenience, EUDA Helixé 2.0 is positioned as a core contribution within EUDA’s rising health and durability ecosystem.
Mr Alfred Lim, CEO of EUDA, expressed:
"This marks a significant milestone in EUDA’s product development. With EUDA Helixé 2.0, we are consolidating our core preparation, advancing delivery technology, and escalating global market convenience through Halal certification. These improvements show our commitment to science-backed invention and position EUDA Helixé as a first-class longevity supplement associated with EUDA’s wider strategy to scale superior-quality wellness options worldwide.”
23 January 2026
23 January 2026
23 January 2026
23 January 2026